328.82
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $328.82, with a volume of 465.32K.
It is down -0.46% in the last 24 hours and up +5.37% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$330.34
Open:
$333.27
24h Volume:
465.32K
Relative Volume:
0.55
Market Cap:
$23.23B
Revenue:
$3.22B
Net Income/Loss:
$542.70M
P/E Ratio:
43.96
EPS:
7.4805
Net Cash Flow:
$458.00M
1W Performance:
+4.55%
1M Performance:
+5.37%
6M Performance:
+22.90%
1Y Performance:
+46.20%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services Inc
|
328.82 | 23.23B | 3.22B | 542.70M | 458.00M | 7.4805 |
|
ISRG
Intuitive Surgical Inc
|
411.06 | 145.58B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
146.24 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
66.85 | 32.60B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.61 | 30.96B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
194.78 | 28.25B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
West Pharmaceutical Services (WST) Is an Injectable-Drug Infrastructure Story, Not Just a Packaging Supplier - AlphaStreet
Is Wall Street bullish or bearish on West Pharmaceutical Services stock? - MSN
West Pharmaceutical Stock (US9553061055): Valuation Metrics Under the Microscope on a Quiet Friday - AD HOC NEWS
West Pharmaceutical Stock (US9523901012): Valuation Metrics Under the Microscope - AD HOC NEWS
West Pharma’s GLP-1 Tailwinds Come With A Cybersecurity Footnote - Finimize
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards - Devdiscourse
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - TradingView
West Pharmaceutical Names Thermo Fisher Executive as CEO - MyChesCo
AMN Expands Language Services Portfolio With Jaide Health Deal - TradingView
Motley Fool Wealth Management LLC Reduces Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Here's what to expect from West Pharmaceutical's next earnings report - MSN
West Pharma raised to overweight at Barclays on fundamentals - MSN
West Pharmaceutical Services Inc (WST) Shares Surge 4.7% -- What GF Score of 96 Tells Investors - GuruFocus
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 - Moomoo
West Pharmaceutical (WST) Boosted to Overweight with Target Rais - GuruFocus
West Pharmaceutical Services appoints Michel Lagarde as next president, CEO - Pennsylvania Business Report -
West Pharmaceutical Services (NYSE:WST) Reaches New 12-Month HighStill a Buy? - MarketBeat
West Pharma stock upgraded at Barclays (WST:NYSE) - Seeking Alpha
West Pharmaceutical Services stock hits 52-week high at 331.43 USD - Investing.com
Barclays upgrades West Pharmaceutical stock rating on GLP-1 outlook By Investing.com - Investing.com Canada
ING Groep NV Sells 17,581 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Wolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug Growth - Insider Monkey
Why Is West Pharmaceutical Drawing Attention Amid Injectable Drug Expansion? - Kalkine Media
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
Los Angeles Capital Management LLC Has $11.95 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST) Stock Analysis: A 12% Upside Potential Amid Robust Revenue Growth - DirectorsTalk Interviews
Wolfe Research Initiates Coverage on West Pharmaceutical Services with Outperform RatingStrong Earnings Momentum - newsline.com
Wolfe Research Initiates Coverage on West Pharmaceutical Services (WST) With Outperform RatingGuidance Revision Trend - newsline.com
Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) Stock - Insider Monkey
How The West Pharmaceutical Services (WST) Story Is Evolving With Guidance Buybacks And New Leadership - Yahoo Finance
West Pharmaceutical Services, Inc. $WST Stock Position Decreased by Natixis Advisors LLC - MarketBeat
CIBC Asset Management Inc Acquires 6,915 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
WST Technical Analysis | Trend, Signals & Chart Patterns | WEST PHARMACEUTICAL SERVICES (NYSE:WST) - ChartMill
Exton's West Pharmaceutical Services Names New CEO as Eric Green Steps Down After 11 Years - VISTA.Today
What Does Eric Green's Retirement Mean for West Pharmaceutical Services - Kavout
West Pharma names former Thermo Fisher executive Lagarde as CEO - ETPharma.com
Billionaire Bill Gates' Foundation Dumped Microsoft but Loaded Up on This Dividend Champion - Yahoo Finance
West Pharmaceutical Names Michel Lagarde Next CEO - The Globe and Mail
Billionaire Bill Gates' Foundation Dumped Microsoft but Loaded Up on This Dividend Champion - The Motley Fool
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services Inc at William Blair Growth Stock Conference Transcript - GuruFocus
West Pharmaceutical Services (WST) Announces Leadership Transiti - GuruFocus
Q1 2026 Life Sciences Earnings Review: PacBio vs. West Pharmaceutical PerformanceNews and Statistics - IndexBox
WST Reiterated by Stephens & Co. -- Price Target Maintained at $360 - GuruFocus
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating - Moomoo
West Appoints Michel Lagarde a President and CEO - Contract Pharma
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services Appoints Michel Lagarde as President and CEO Effective August 31, 2026 - Minichart
West Pharmaceutical names Michel Lagarde as next CEO By Investing.com - Investing.com Australia
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):